Animal Health Investment USA

Boston, April 10 – April 11, 2019

The animal health industry is changing. Since the Zoetis spin-out from Pfizer we’ve seen further companies such as Elanco follow suit with successful IPO’s.

Investors are beginning to take notice, however questions still remain regarding the opportunities in the industry:
   -  What does animal health really offer investors when compared to human health?
   -  In what ways can human biotech’s leverage the space to maximize their own technology?

Our investor conference in Boston will answer these questions and bring together domain experts and market leading companies to present the current trends and dynamics of the animal health industry and to outline where capital investment can make an impact.


!!! For more information or to RSVP click here or contact Chiara Russo ( !!!

Additional menu options can be found in the menu bar on the left or at the top.